Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Dickins

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 2011
Application of PBPK modelling in drug discovery and development at PfizerHannah M Jones, Maurice Dickins, Kuresh Youdim, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Malaria Journal|January 4, 2020
An in vitro toolbox to accelerate anti-malarial drug discovery and developmentSusan A Charman, Alice Andreu, Helena Barker, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 2011
Application of PBPK modelling in drug discovery and development at PfizerHannah M Jones, Maurice Dickins, Kuresh Youdim, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Malaria Journal|January 4, 2020
An in vitro toolbox to accelerate anti-malarial drug discovery and developmentSusan A Charman, Alice Andreu, Helena Barker, et al.
Pageof 3